Fdc Ltd vs Haleos Labs Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of FDC Ltd is ₹ 364.55 as of 04 May 09:20 . The P/E Ratio of FDC Ltd changed from 16 on March 2021 to 24.1 on March 2025 . This represents a CAGR of 8.54% over 5 yearsThe P/E Ratio of Haleos Labs Limited changed from 11 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 8.05% over 5 years The Market Cap of FDC Ltd changed from ₹ 4822 crore on March 2021 to ₹ 6419 crore on March 2025 . This represents a CAGR of 5.89% over 5 yearsThe Market Cap of Haleos Labs Limited changed from ₹ 149.61 crore on March 2021 to ₹ 326.64 crore on March 2025 . This represents a CAGR of 16.90% over 5 years The revenue of FDC Ltd for the Dec '25 is ₹ 485.51 crore as compare to the Sep '25 revenue of ₹ 493.66 crore. This represent the decline of -1.65% The revenue of Haleos Labs Limited for the Dec '25 is ₹ 94.97 crore as compare to the Sep '25 revenue of ₹ 81.79 crore. This represent the growth of 16.11% The ebitda of FDC Ltd for the Dec '25 is ₹ 52.29 crore as compare to the Sep '25 ebitda of ₹ 54.44 crore. This represent the decline of -3.95% The ebitda of Haleos Labs Limited for the Dec '25 is ₹ 14.23 crore as compare to the Sep '25 ebitda of ₹ 13.99 crore. This represent the growth of 1.72% The net profit of FDC Ltd changed from ₹ 119.04 crore to ₹ 28.3 crore over 7 quarters. This represents a CAGR of -56.00% The net profit of Haleos Labs Limited changed from ₹ 7.1 crore to ₹ 6.65 crore over 7 quarters. This represents a CAGR of -3.67% The Dividend Payout of FDC Ltd changed from 29.75 % on March 2025 to 29.75 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Haleos Labs Limited changed from 3.44 % on March 2021 to 2.12 % on March 2025 . This represents a CAGR of -9.23% over 5 years .

About FDC Ltd

FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About Haleos Labs Limited

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

FAQs for the comparison of FDC Ltd and Haleos Labs Limited

Which company has a larger market capitalization, FDC Ltd or Haleos Labs Limited?

Market cap of FDC Ltd is 5,937 Cr while Market cap of Haleos Labs Limited is 445 Cr

What are the key factors driving the stock performance of FDC Ltd and Haleos Labs Limited?

The stock performance of FDC Ltd and Haleos Labs Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and Haleos Labs Limited?

As of May 4, 2026, the FDC Ltd stock price is INR ₹364.7. On the other hand, Haleos Labs Limited stock price is INR ₹1474.9.

How do dividend payouts of FDC Ltd and Haleos Labs Limited compare?

To compare the dividend payouts of FDC Ltd and Haleos Labs Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.